Skip to main content
. 2022 Dec 16;4(1):101953. doi: 10.1016/j.xpro.2022.101953

Figure 2.

Figure 2

Characterization of hPSC and hPSC-derived endothelial progenitor cells

(A) Immunostaining analysis for OTC4 and SSEA4 expression on human pluripotent stem cells.

(B) Immunostaining analysis for Sox17 and VE-cadherin (VEcad) expression on hPSC-derived endothelial progenitors (EPs) on day 6.

Scale bars, 50 μm.